The law of biologic medicine : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, second session, June 23, 2004.

Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003.
Published: (2004)

Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003.
Published: (2004)

FDA's generic drug application policy : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988.
Published: (1989)

Closing the gaps in Hatch-Waxman : assuring greater access to affordable pharmaceuticals : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, second session, on examining certain provisions of the 1984 Drug Price Competition and Patent Term Restoration Act, known as the Hatch-Waxman Act, assuring greater access to affordable pharmaceuticals, May 8, 2002.
Published: (2002)

Biosimilar implementation : a progress report from FDA : hearing before the Subcommittee on Primary Health and Retirement Security of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, first session ... September 17, 2015.
Published: (2017)

Protecting Consumer Access to Generic Drugs Act of 2007 : hearing before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, on H.R. 1902, May 2, 2007.
Published: (2007)

H.R. 1706, the Protecting Consumer Access to Generic Drugs Act of 2009 : hearing before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, March 31 2009.
Published: (2012)

Protecting Consumer Access to Generic Drugs Act of 2007 : hearing before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, on H.R. 1902, May 2, 2007.
Published: (2007)

Generic drugs : stakeholders views on improving FDA's information on patents : report to congressional committees /
Published: (2023)

Generic drug laws : a decade of trial, a prescription for progress /
Published: (1986)

Expanding the use of generic drugs.
Published: (2010)

Authorized generics : an interim report.
Published: (2009)

Las drogas baratas aprobadas por la FDA : los productos genéricos deben satisfacer altos niveles.
Published: (2004)

FDA-approved bargain drugs : generic products must meet high standards.
Published: (2003)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

"Skinny labels" for generic drugs under Hatch-Waxman /
by: Hickey, Kevin J.
Published: (2024)

Making Objective Drug Evidence Revisions for New Labeling Act of 2020 : report (to accompany H.R. 5668) (including cost estimate of the Congressional Budget Office).
Published: (2020)

Committee prints on administration legislative proposals on the Animal Drug User Fee Act Amendments of 2008 and the Animal Generic Drug User Fee Act of 2008 : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, June 5, 2008.
Published: (2008)

Reauthorization of animal drug user fees : ADUFA and AGDUFA : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, April 9, 2013.
Published: (2013)

Pay to delay : are patent settlements that delay generic drug market entry anticompetitive? : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, June 3, 2009.
Published: (2010)

Increasing generic drug use : savings for seniors and Medicare : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, second session, Washington, DC, September 21, 2006.
Published: (2007)

Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002.
Published: (2004)

Assessing the impact of a safe and equitable biosimilar policy in the United States : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007.
Published: (2008)

Safe and affordable biotech drugs : the need for a generic pathway : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, March 26, 2007.
Published: (2008)

Food and drug law and regulation /
Published: (2008)

Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, January 17, 2007.
Published: (2007)

Generic drug entry prior to patent expiration : an FTC study /
Published: (2002)

Pay-for-delay deals : limiting competition and costing consumers : hearing before the Subcommittee on Antitrust, Competition Policy and Consumer Rights of the Committee on the Judiciary, United States Senate, One Hundred Thirteenth Congress, first session, July 23, 2013.
Published: (2013)

Animal Generic Drug User Fee Act of 2008 : report (to accompany H.R. 6433) (including cost estimate of the Congressional Budget Office).
Published: (2008)

A plan for action : phase II.
Published: (1987)

Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002.
Published: (2002)

Pharmaceutical patent issues : interpreting GATT : hearings before the Committee on the Judiciary, United States Senate, One Hundred Fourth Congress, second session ... S. 1277, a bill to provide equitable relief for the generic drug industry, and for other purposes, February 27, and March 5, 1996.
Published: (1997)

Research and development of vaccines and pharmaceuticals from biotechnology : a guide to effective project management, patenting, and product registration /
by: Gregersen, Jens-Peter
Published: (1994)

Closing the gaps in Hatch-Waxman : assuring greater access to affordable pharmaceuticals : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, second session, on examining certain provisions of the 1984 Drug Price Competition and Patent Term Restoration Act, known as the Hatch-Waxman Act, assuring greater access to affordable pharmaceuticals, May 8, 2002.
Published: (2002)

FDA has made progress on oversight and inspections of manufacturers of generic drugs.
Published: (2015)

Authorized generic drugs : short-term effects and long-term impact.
Published: (2011)